Asosiy kontentga oʻtish
Maqola

"Efficacy of Treatment Regimens for Sodium-Glucose Counter Transporter 2 Inhibitor (Emaglyf) with Metformin and DPP-4 Inhibitor (Januvia) in Patients with Type 2 Diabetes Mellitus with Stage 1-3 Chronic Kidney Disease"

Teshabekova Mohira KudratovnaResident Physician at the Department of Diabetic Nephropathy, RSNPMTSE named by acad Y.Kh. Turakulov, Republic of Uzbekistan
2022en
ABI

Annotatsiya

Efficacy of Treatment Regimens for Sodium-Glucose Counter Transporter 2 Inhibitor (Emaglyf) with Metformin and DPP-4 Inhibitor (Januvia) in Patients with Type 2 Diabetes Mellitus with Stage 1-3 Chronic Kidney Disease.Biomed

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar